PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Alpha-Glucosidase 4,319 Target Target Lysosomal Alpha-Glucosidase 105 105 0.16 -0.10 1.00 0.79
AMAC-1 19 Target Target CCL18 256 4 0.06 -0.88 0.21 0.79
Aurora B kinase 415 Target Target Aurora A kinase 318 14 0.04 -0.96 0.04 0.79
Draflazine 33 Drug Target Ent2 108 2 0.03 -0.96 0.06 0.79
APOA1 958 Target Target APOA2 118 25 0.07 -0.88 0.21 0.79
CXCL7 76 Target Target CXCL4/PF4 9 1 0.04 -0.94 0.11 0.79
CCL4 5,638 Target Target CCL5 2,002 316 0.09 -0.89 0.16 0.79
Draflazine 33 Drug Target Equilibrative Nucleoside Transporter 1 211 4 0.05 -0.93 0.12 0.79
CCL18 256 Target Target CCL14 34 5 0.05 -0.91 0.15 0.79
EPHA3 140 Target Target EPHB2 385 11 0.05 -0.95 0.08 0.79
CCL8 197 Target Target CXCL2 750 24 0.06 -0.92 0.12 0.79
EPHA4 357 Target Target EPHB3 118 10 0.05 -0.94 0.08 0.79
bFGF 9,327 Target Target aFGF 899 448 0.15 -0.69 0.50 0.79
CXCL11 526 Target Target CCL8 197 17 0.05 -0.94 0.09 0.79
ELC 355 Target Target Exodus-3 8 5 0.09 -0.61 0.62 0.79
CCL7 274 Target Target CCL3 1,427 51 0.08 -0.89 0.19 0.79
ELC 355 Target Target Exodus-2 27 7 0.07 -0.85 0.26 0.79
CCL18 256 Target Target CCL1 220 9 0.04 -0.96 0.04 0.80
CCL7 274 Target Target CCL14 34 6 0.06 -0.90 0.18 0.80
CAMK2A 42 Target Target CAMK4 43 1 0.02 -0.98 0.02 0.80
EPHB4 329 Target Target EPHA2 532 21 0.05 -0.95 0.06 0.80
CCL2 3,560 Target Target CXCL9 1,016 190 0.10 -0.88 0.19 0.80
BMP-6 386 Target Target BMP-2 3,889 163 0.13 -0.74 0.42 0.80
CCL19 658 Target Target ELC 355 28 0.06 -0.94 0.08 0.80
CD1A 2,739 Target Target CD68 6,424 458 0.11 -0.88 0.17 0.80
D(1a) Dopamine Receptor 51 Target Target D(2) Dopamine Receptor 1,559 41 0.15 -0.44 0.80 0.80
Epiregulin 291 Target Target beta-Cellulin 17 6 0.09 -0.80 0.35 0.80
CA 72-4 184 Target Target CA 15-3 898 34 0.08 -0.89 0.18 0.80
BAFF 1,240 Target Target BAFFR 44 33 0.14 -0.49 0.75 0.80
CCL2 3,560 Target Target CXCL2 750 192 0.12 -0.84 0.26 0.80
EPHA3 140 Target Target EPHB1 137 5 0.04 -0.96 0.04 0.80
CCL7 274 Target Target CXCL3 145 10 0.05 -0.95 0.07 0.80
BMX 185 Target Target BTK 1,263 49 0.10 -0.84 0.26 0.80
CAMK2D 21 Target Target CAMK4 43 1 0.03 -0.96 0.05 0.80
CXCL10/IP-10 114 Target Target CXCL9 1,016 37 0.11 -0.81 0.32 0.81
Cytokeratin 8 587 Target Target Cytokeratin 18 1,108 60 0.07 -0.92 0.10 0.81
CCL7 274 Target Target CXCL2 750 34 0.08 -0.91 0.12 0.81
Antithrombin 13,773 Target Target D-Dimer 6,185 1,337 0.14 -0.84 0.22 0.81
CCN5 57 Target Target CYR61 539 17 0.10 -0.82 0.30 0.81
CCL7 274 Target Target CCL2 3,560 164 0.17 -0.62 0.60 0.81
EPHA4 357 Target Target EPHB1 137 14 0.06 -0.93 0.10 0.81
Cathepsin G 1,613 Target Target Elastase 13,875 985 0.21 -0.60 0.61 0.81
EPHB4 329 Target Target EPHB1 137 13 0.06 -0.93 0.09 0.81
Artemin 184 Target Target Enovin 3 3 0.13 -0.50 1.00 0.81
Epigen 27 Target Target Epiregulin 291 8 0.09 -0.83 0.30 0.81
CXCL7 76 Target Target CCL8 197 7 0.06 -0.94 0.09 0.81
Des (1-3) IGF-I 191 Target Target Des (1-6) IGF-II 18 5 0.09 -0.84 0.28 0.81
CCL14 34 Target Target CCL8 197 6 0.07 -0.89 0.18 0.81
DAPK2 27 Target Target DAPK1 205 6 0.08 -0.87 0.22 0.81
CCL14 34 Target Target Eotaxin-3/CCL26 26 1 0.03 -0.97 0.04 0.81